HighTower Advisors LLC purchased a new stake in CareCloud, Inc. (NASDAQ:CCLD – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 20,084 shares of the company’s stock, valued at approximately $28,000.
Several other large investors have also recently added to or reduced their stakes in the company. XTX Topco Ltd acquired a new position in shares of CareCloud in the 1st quarter valued at $35,000. Kingsview Wealth Management LLC acquired a new position in shares of CareCloud in the 1st quarter valued at $36,000. Axxcess Wealth Management LLC acquired a new position in shares of CareCloud in the 1st quarter valued at $41,000. Colonial River Investments LLC acquired a new position in shares of CareCloud in the 1st quarter valued at $41,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of CareCloud by 31.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 15,096 shares of the company’s stock valued at $55,000 after buying an additional 3,641 shares in the last quarter. Institutional investors and hedge funds own 10.16% of the company’s stock.
Insider Buying and Selling
In related news, Director John N. Daly sold 15,000 shares of the stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $2.11, for a total transaction of $31,650.00. Following the sale, the director directly owned 61,750 shares in the company, valued at $130,292.50. This represents a 19.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 14.70% of the stock is currently owned by company insiders.
CareCloud Trading Down 0.3%
CareCloud (NASDAQ:CCLD – Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). The business had revenue of $27.38 million for the quarter, compared to the consensus estimate of $27.19 million. CareCloud had a return on equity of 23.51% and a net margin of 10.08%. CareCloud has set its FY 2025 guidance at 0.100-0.130 EPS. As a group, equities research analysts predict that CareCloud, Inc. will post 0.58 EPS for the current year.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded shares of CareCloud from a “hold” rating to a “buy” rating in a research note on Sunday, July 13th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $2.50.
Read Our Latest Analysis on CareCloud
CareCloud Profile
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
See Also
- Five stocks we like better than CareCloud
- How to Effectively Use the MarketBeat Ratings Screener
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- What is the Nikkei 225 index?
- Lululemon Share Price Has Plenty of Room Left to Fall
- Top Stocks Investing in 5G Technology
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Want to see what other hedge funds are holding CCLD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CareCloud, Inc. (NASDAQ:CCLD – Free Report).
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.